Physician profile
Robin Allen
NPI 1750398038
$6,220.45
in general payments reported to CMS, 2019-2025
28 companies · $1,396 in 2025
The $1,396 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $836 · 2022: $1,450 · 2023: $1,132 · 2024: $1,407 · 2025: $1,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,934.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,236.70 | 2021-2025 | Leqvio |
| Abbott Laboratories | $960.64 | 2021-2025 | Cardiomems, Merlin@Home, Aveir |
| Boehringer Ingelheim Pharmaceuticals, INC. | $577.11 | 2021-2025 | Jardiance |
| Pfizer INC. | $494.72 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $454.14 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| E.R. Squibb & Sons, L.L.C. | $436.30 | 2023-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $343.59 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $322.02 | 2021-2025 | |
| Amgen INC. | $286.91 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $197.50 | 2022-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.34 | 2023-2025 | Lifevest |
| Esperion Therapeutics, INC. | $138.08 | 2021-2025 | Nexletol |
| Impulse Dynamics (USA) INC. | $94.23 | 2022 | |
| Novo Nordisk INC | $71.83 | 2024-2025 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $64.32 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $50.74 | 2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm |
| Medtronic, INC. | $46.64 | 2025 | Micra |
| Philips North America LLC | $43.60 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Cvrx, INC. | $36.86 | 2025 | Barostim Neo System |
| Scpharmaceuticals INC. | $36.46 | 2024-2025 | |
| Amarin Pharma, INC. | $31.59 | 2021 | |
| Abiomed | $30.02 | 2024 | Impella |
| Heartflow, INC. | $24.43 | 2024 | |
| Kerecis Limited | $24.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cardiovascular Systems INC. | $23.28 | 2021 | |
| Silk Road Medical, INC. | $20.57 | 2021 | |
| Boston Scientific Corporation | $18.95 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.